Increasing Burden of Chronic Liver Disease Among Adolescents and Young Adults in the USA: A Silent Epidemic

Digestive Diseases and Sciences

Volumn 62, Issue 5, 2017, Pages 1373-1380

  Doycheva, Iliana ^a   Watt, Kymberly D ^b   Rifai, Ghassoub ^c   Abou Mrad, Rachel ^c   Lopez, Rocio ^c   Zein, Nizar N ^c   Carey, William D ^c   Alkhouri, Naim ^c,d  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b MAYO CLINIC   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d Clevel and Clinic   (United States)

Author keywords

Alcoholic liver disease; Hepatitis C; Nonalcoholic fatty liver disease; Obesity; Young population

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; VIRUS RNA;

ADOLESCENT; ADOLESCENT HEALTH; ADULT; AGE; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ARTICLE; BODY WEIGHT; CHRONIC LIVER DISEASE; CROSS-SECTIONAL STUDY; DISEASE ASSESSMENT; ETHNICITY; FEMALE; GENDER; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; UNITED STATES; END STAGE LIVER DISEASE; YOUNG ADULT;

ADOLESCENT; ADULT; END STAGE LIVER DISEASE; FEMALE; HUMANS; MALE; RISK FACTORS; UNITED STATES; YOUNG ADULT;

EID: 85012266424     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-017-4492-3     Document Type: Article

References (39)

1. United States Census Bureau. Estimates of U.S. Population by Age and Sex: April 1, 2010, to July 1, 2015. Available at: http://factfinder.census.gov/faces/tableservices/jsf/pages/productview.xhtml?src=bkmk. Accessed October 31, 2016.
2. Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in obesity among adults in the United States, 2005 to 2014. JAMA. 2016;315:2284–2291.
3. Kann L, McManus T, Harris WA, et al. Youth risk behavior surveillance—United States, 2015. MMWR Surveill Summ. 2016;65:1–174.
4. Mehta SH, Astemborski J, Kirk GD, et al. Changes in blood-borne infection risk among injection drug users. J Infect Dis. 2011;203:587–594.
5. Suryaprasad AG, White JZ, Xu F, et al. Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006–2012. Clin Infect Dis. 2014;59:1411–1419.
6. Zibbell JE, Iqbal K, Patel RC, et al. Increases in hepatitis C virus infection related to injection drug use among persons aged
7. Heron M. Deaths: leading causes for 2013. Natl Vital Stat Rep. 2016;65:1–95.
8. CDC. NCHS. Key concepts about NHANES survey design. Available at: http://www.cdc.gov/nchs/tutorials/Nhanes/SurveyDesign/SampleDesign/Info1.htm. Accessed October 31, 2016.
9. Johnson CL, Paulose-Ram R, Ogden CL, et al. National health and nutrition examination survey: analytic guidelines, 1999–2010. Vital Health Stat. 2013;2:1–24.
10. Mrad RA, Merjaneh N, Mubarak G, Lopez R, Zein NN, Alkhouri N. The increasing burden of nonalcoholic fatty liver disease among young adults in the United States: a growing epidemic [Letter to the Editor]. Hepatology. 2016;64:1386–1387.
11. Alkhouri N, Hanouneh IA, Zein NN, et al. Liver transplantation for nonalcoholic steatohepatitis in young patients. Transpl Int. 2016;29:418–424.
12. Wong RJ, Aguilar M, Cheung R, et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology. 2015;148:547–555.
13. Singh GK, Vitola BE, Holland MR, et al. Alterations in ventricular structure and function in obese adolescents with nonalcoholic fatty liver disease. J Pediatr. 2013;162:1160–1168, 1168 e1161.
14. Office of the Surgeon General (US), Office of Disease Prevention and Health Promotion (US), Centers for Disease Control and Prevention (US), National Institutes of Health (US). The surgeon general’s call to action to prevent and decrease overweight and obesity. Rockville (MD): Office of the Surgeon General (US); 2001. Available from: https://www.ncbi.nlm.nih.gov/books/NBK44206/.
15. Hurt RT, Kulisek C, Buchanan LA, McClave SA. The obesity epidemic: challenges, health initiatives, and implications for gastroenterologists. Gastroenterol Hepatol (N Y). 2010;6:780–792.
16. Lewis CE, Jacobs DR Jr, McCreath H, et al. Weight gain continues in the 1990s: 10-year trends in weight and overweight from the CARDIA study. Coronary artery risk development in young adults. Am J Epidemiol. 2000;151:1172–1181.
17. Lytle LA, Svetkey LP, Patrick K, et al. The EARLY trials: a consortium of studies targeting weight control in young adults. Transl Behav Med. 2014;4:304–313.
18. Barnes PM, Schoenborn CA. Trends in adults receiving a recommendation for exercise or other physical activity from a physician or other health professional. NCHS Data Brief. 2012; 1–8.
19. Mathurin P, Deltenre P. Effect of binge drinking on the liver: an alarming public health issue? Gut. 2009;58:613–617.
20. Trimble G, Zheng L, Mishra A, Kalwaney S, Mir HM, Younossi ZM. Mortality associated with alcohol-related liver disease. Aliment Pharmacol Ther. 2013;38:596–602.
21. Denniston MM, Jiles RB, Drobeniuc J, et al. Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010. Ann Intern Med. 2014;160:293–300.
22. CDC. Surveillance for Viral Hepatitis—United States, 2014. Available at: http://www.cdc.gov/hepatitis/statistics/2014surveillance/index.htm. Page last updated: June 22, 2016. Accessed October 31, 2016.
23. Koneru A, Nelson N, Hariri S, et al. Increased hepatitis C virus (HCV) detection in women of childbearing age and potential risk for vertical transmission—United States and Kentucky, 2011–2014. Morb Mortal Wkly Rep. 2016;65:705–710.
24. Hepatitis C virus infection in young persons who inject drugs. Consultation Report. February 26–27, 2013. https://www.aids.gov/pdf/hcv-and-young-pwid-consultation-report.pdf. Accessed January 3, 2017.
25. Hagan H, Campbell J, Thiede H, et al. Self-reported hepatitis C virus antibody status and risk behavior in young injectors. Public Health Rep. 2006;121:710–719.
26. Welsh JA, Karpen S, Vos MB. Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988–1994 to 2007–2010. J Pediatr. 2013;162(496–500):e491.
27. Twig G, Yaniv G, Levine H, et al. Body-Mass Index in 2.3 million adolescents and cardiovascular death in adulthood. N Engl J Med. 2016;374:2430–2440.
28. Adams KF, Leitzmann MF, Ballard-Barbash R, et al. Body mass and weight change in adults in relation to mortality risk. Am J Epidemiol. 2014;179:135–144.
29. Hagstrom H, Stal P, Hultcrantz R, Hemmingsson T, Andreasson A. Overweight in late adolescence predicts development of severe liver disease later in life: A 39 years follow-up study. J Hepatol. 2016;65:363–368.
30. Hassan MM, Abdel-Wahab R, Kaseb A, et al. Obesity early in adulthood increases risk but does not affect outcomes of hepatocellular carcinoma. Gastroenterology. 2015;149:119–129.
31. Colby SL, Ortman JM. Projections of the size and composition of the U.S. Population: 2014 to 2060. Current Population Reports, P25-1143, U.S. Census Bureau, Washington, DC, 2014.
32. Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40:1387–1395.
33. Williams CD, Stengel J, Asike MI, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140:124–131.
34. Neuschwander-Tetri BA, Clark JM, Bass NM, et al. Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology. 2010;52:913–924.
35. Northcote J, Livingston M. Accuracy of self-reported drinking: observational verification of ‘last occasion’ drink estimates of young adults. Alcohol Alcohol. 2011;46:709–713.
36. Younossi ZM, Stepanova M, Negro F, et al. Nonalcoholic fatty liver disease in lean individuals in the United States. Medicine (Baltimore). 2012;91:319–327.
37. Schwimmer JB, Newton KP, Awai HI, et al. Paediatric gastroenterology evaluation of overweight and obese children referred from primary care for suspected non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2013;38:1267–1277.
38. Peery AF, Crockett SD, Barritt AS, et al. Burden of gastrointestinal, liver, and pancreatic diseases in the United States. Gastroenterology. 2015;149(1731–1741):e1733.
39. Stepanova M, De Avila L, Afendy M, et al. Direct and indirect economic burden of chronic liver disease in the United States. Clin Gastroenterol Hepatol. 2016. doi:10.1016/j.cgh.2016.07.020.